Bonspri Solution for Injection
Marketer
Novartis India Ltd
Salt Composition
Ofatumumab (20mg/0.4ml)
Overview Bonspri Solution for Injection
Injected Cytol (trade name) is indicated for chronic lymphocytic leukemia management. Its mechanism involves receptor binding on leukemic cells, marking them for immune system elimination. Cytol is administered intravenously under medical supervision. Dosage and frequency are determined by your physician based on individual needs and may vary. Adhere strictly to prescribed instructions; incorrect usage or overdose can have serious consequences. Therapeutic effects may not be immediately apparent, possibly taking weeks or months; discontinue only under medical guidance. Common adverse reactions include nausea, diarrhea, dyspnea, and cough. Report any persistent or bothersome side effects to your doctor. Regular blood tests monitoring blood counts, cardiac, hepatic, and renal function are essential. Prior to treatment, disclose any pre-existing heart, liver, or kidney conditions, and list all current medications, including antibiotics, as drug interactions are possible. This medication is contraindicated during pregnancy and lactation; effective contraception is mandatory for both partners throughout the treatment period.
Primary Ingredients of Bonspri Solution for Injection
No information provided. Please provide the text you wish me to rephrase.
Uses of Bonspri Solution for Injection
Chronic lymphocytic leukemia, a type of blood malignancy.
Major Benefits of Bonspri Solution for Injection:
Medical professionals will instruct you on the proper administration of this medication.
Common Side effects of Bonspri Solution for Injection:
- Nausea
- Diarrhea
- Breathlessness
- Cough
- Flushing of skin
- Low energy
- Skin rash
How to use Bonspri Solution for Injection:
Your healthcare provider will instruct you on the proper administration of this medication.
How Bonspri Solution for Injection works:
Bonspri Injectable Solution, a monoclonal antibody, targets specific receptors on cancerous cells, marking them for elimination by the patient's own immune response.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Bonspri Injectable Solution has an undetermined safety profile. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Administering Bonspri Injection Solution during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible dangers prior to prescription. Seek medical advice.
Breast feedingSAFE IF PRESCRIBED
Administering Bonspri Solution for Injection while breastfeeding is likely safe. Available human data indicates minimal risk to the infant.
DrivingCONSULT YOUR DOCTOR
The impact of Bonspri Injectable Solution on driving ability is undetermined. Refrain from driving if you develop symptoms impairing concentration or reaction time.
KidneySAFE IF PRESCRIBED
Bonspri injectable solution poses no safety concerns for patients with renal impairment; no dosage modification is necessary.
LiverUNSAFE
The use of Bonspri Injection Solution in individuals with hepatic impairment is potentially hazardous and should be avoided. Medical advice is recommended.
What if you forget to take Bonspri Solution for Injection :
NA
Facts to Know About Bonspri Solution for Injection
| Label | Value |
|---|---|
| Chemical Type | Monoclonal antibody |
| Developing Habits | No. |
| Treatment Category | Cancer Medications |
| Active Class | Anti-CD20 Therapy |
3,018 People bought this recently